ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2022

Dec 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2022-12-21

Reporting Person: O'Brien Patrick (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-21	Common Stock	M	32000	$6.15	Acquired	380875	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-21	Stock Option (right to buy Common Stock)	$6.15	M	32000	Disposed	2026-01-01	Common Stock (32000)	Direct

Footnotes

F1: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the reporting person which are subject to certain vesting conditions.

F2: Represents the first vesting date. Option vested over four years from date of grant.